Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. The appointee is expected to reside in the Helsinki Metropolitan Area during the employment. QUALIFICATIONS AND EVALUATION Applicants are required to hold a PhD in a relevant field, such as memory studies
-
funding. The start date is 1 September 2026. The appointee is expected to reside in the Helsinki Metropolitan Area during the employment. QUALIFICATIONS AND EVALUATION Applicants are required to hold a PhD
-
for candidates with an excellent track-record of research performance with post-doctoral experience. The qualifications include: PhD degree from a relevant field Postdoctoral experience Excellent scientific track
-
data. We are looking for candidates with an excellent track-record of research performance with post-doctoral experience. The qualification include: PhD degree from a relevant field within the past 12
-
programme under the Marie Skłodowska-Curie Action (MSCA), University of Helsinki is offering a PhD fellowship for a Doctoral Candidate (DC), starting 1 September 2026 or as soon as possible hereafter. A
-
programme under the Marie Skłodowska-Curie Action (MSCA), University of Helsinki is offering a PhD fellowship for a Doctoral Candidate (DC), starting 1 September 2026 or as soon as possible hereafter. A
-
Action (MSCA), University of Helsinki is offering a PhD fellowship for a Doctoral Candidate (DC), starting 1 September 2026 or as soon as possible hereafter. A position is for 36 months and is funded by
-
Action (MSCA), University of Helsinki is offering a PhD fellowship for a Doctoral Candidate (DC), starting 1 September 2026 or as soon as possible hereafter. A position is for 36 months and is funded by
-
cutting-edge genome editing and single-cell approaches in cell lines and in patient samples. The research group is led by Mikko Myllymäki, MD, PhD and our research group is located at the Institute
-
integrate large population-level cohort analyses with cutting-edge genome editing and single-cell approaches in cell lines and in patient samples. The research group is led by Mikko Myllymäki, MD, PhD and